Literature DB >> 8915467

Assessing the impact of comorbidity in the older population.

J M Guralnik1.   

Abstract

Comorbidity is common in the older population. A variety of assessment techniques have been used for measurement of comorbidity and have demonstrated the association of increased level of comorbidity with a variety of adverse health outcomes. The most basic measure of comorbidity is a sum of the number of conditions present. Two general approaches have been used to incorporate disease severity measures into comorbidity indices: assignment of severity scores to all relevant conditions with summation of these scores, and assignment of comorbidity severity based on the most severe comorbid disease present. Each of these approaches has strengths and limitations. Research focusing on an index condition and associated comorbidity has been valuable in describing the impact of comorbidity in a number of different disease states.

Mesh:

Year:  1996        PMID: 8915467     DOI: 10.1016/s1047-2797(96)00060-9

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  55 in total

1.  [Use of a proxy to the Charlson index to study the short and long-term comorbidity and mortality in the elderly].

Authors:  Alicia Gutiérrez-Misis; Maite Sánchez-Santos; Ángel Otero
Journal:  Aten Primaria       Date:  2011-06-01       Impact factor: 1.137

2.  Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis.

Authors:  Amresh D Hanchate; Kerri M Clough-Gorr; Arlene S Ash; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Gen Intern Med       Date:  2010-06-08       Impact factor: 5.128

Review 3.  [Comorbidity oriented oncology - an overview].

Authors:  Ralph Simanek; Michael Wuensch; Roland Edlinger; Bernhard Hammerl-Ferrari; Ludwig Kramer; Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

4.  Older women's experience with breast cancer treatment decisions.

Authors:  Mara A Schonberg; Robyn L Birdwell; Brittany L Bychkovsky; Lindsay Hintz; Valerie Fein-Zachary; Michael D Wertheimer; Rebecca A Silliman
Journal:  Breast Cancer Res Treat       Date:  2014-03-31       Impact factor: 4.872

5.  Factors noted to affect breast cancer treatment decisions of women aged 80 and older.

Authors:  Mara A Schonberg; Rebecca A Silliman; Ellen P McCarthy; Edward R Marcantonio
Journal:  J Am Geriatr Soc       Date:  2012-01-27       Impact factor: 5.562

6.  Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy.

Authors:  You-qun Huang; Rong Gou; Yong-shu Diao; Qing-hua Yin; Wen-xing Fan; Ya-ping Liang; Yi Chen; Min Wu; Li Zang; Ling Li; Jing Zang; Lu Cheng; Ping Fu; Fang Liu
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

7.  Satisfaction about Patient-centeredness and Healthcare System among Patients with Chronic Multimorbidity.

Authors:  Chao-Hua Zhou; Shang-Feng Tang; Xu-Hui Wang; Zhuo Chen; Dong-Ian Zhang; Jun-Liang Gao; Bishwajit Ghose; Da Feng; Zhi-Fei He; Sanni Yaya; Zhan-Chun Feng
Journal:  Curr Med Sci       Date:  2018-03-15

8.  Women, Aging, and HIV: Clinical Issues and Management Strategies.

Authors:  Julie A Womack; Cynthia A Brandt; Amy C Justice
Journal:  J Nurse Pract       Date:  2014-06-01       Impact factor: 0.767

9.  Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.

Authors:  Jennifer H Jordan; Soe Soe Thwin; Timothy L Lash; Diana S M Buist; Terry S Field; Reina Haque; Pamala A Pawloski; Hans V Petersen; Marianne N Prout; Virginia P Quinn; Marianne Ulcickas Yood; Rebecca A Silliman; Ann M Geiger
Journal:  Breast Cancer Res Treat       Date:  2014-06-18       Impact factor: 4.872

10.  Poor survival for veterans with pathologic stage I non-small-cell lung cancer.

Authors:  Jamii B St Julien; Rhonda Pinkerman; Melinda C Aldrich; Heidi Chen; Stephen A Deppen; Carol Callaway-Lane; Pierre Massion; Joe B Putnam; Eric S Lambright; Jonathan C Nesbitt; Eric L Grogan
Journal:  Am J Surg       Date:  2012-08-18       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.